CLINICAL_TRIALS
trial_result
· 2009-09-02
Clinical Trial Update: Randomized Study of Real-Time Continuous Glucose Monitors (RT-CGM) in the Management of Type 1 Diabetes [Phase 3]
Summary
A Phase 3 randomized trial assessing real-time continuous glucose monitors for Type 1 diabetes has completed and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Jaeb Center for Health Research | Conditions: Type 1 Diabetes | Phase 3 | Status: COMPLETED | Results posted: 2009-09-02